Senior insider sale
Chief Medical Officer at REGENXBIO INC. — senior position signals high conviction
$902.9K
78.12K shares
What this filing means
PAKOLA STEVE plans to sell 78.12K shares of REGENXBIO INC. valued at approximately $902.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001950047-26-006719
Officer· Chief Medical Officer
Since Apr 2019
78.12K
Shares to sell
$902.9K
Approx. market value
43.21K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
7/1/2026
43.21KTotal acquired43.21K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Exercise of Stock Options Cash | 43.21K | — |
| Total | 43.21K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
19.61K
Market value
$216.6K
6/29/2026
—Completed
Units to sell
15.31K
Market value
$168.7K
5/11/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
43.21K
Market value
$517.6K
7/1/2026
Total
Units
78.12K
Value
$902.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/29/2026 | 19.61K | $216.6K | — | Completed |
5/11/2026 | 15.31K | $168.7K | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 43.21K | $517.6K | NASDAQ | Planned |
| Total | 78.12K | $902.9K | ||